Navigation Links
SynCardia Total Artificial Heart Patient with End-Stage Renal Failure Recovers Kidney Function after Two Months of Support
Date:2/21/2013

02130225/Children-s-patient-pioneer-artificial-heart?nclick_check=1

CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,100 implants of the Total Artificial Heart, accounting for more than 300 patient years of life.

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

Forbes Ranks SynCardia #69 Among "America's Most Promising Companies"

In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was selected #69, moving up eight spots from its #77 ranking last year. See the full list of SynCardia Awards & Recognition

SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SynCardia Posts Record Revenue and Profit in Q1 2012
2. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
3. 1st SynCardia Total Artificial Heart Implant Performed in New England
4. 50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox
5. SynCardias Record-Setting Q2 Marks 5th Consecutive Profitable Quarter
6. EJK Duisburg Becomes One of the Most Active SynCardia Certified Centers in Europe
7. SynCardia Total Artificial Heart Patient Featured in U.S. News & World Reports "Best Hospitals" Issue
8. 1st SynCardia Total Artificial Heart Patient Discharged from Ankara University in Turkey
9. University of Washington Leads All SynCardia Certified Centers with 10 Implants of the Total Artificial Heart in 2012
10. Forbes Ranks SynCardia Among "Americas Most Promising Companies" for Second Straight Year
11. Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... 2014   NuVascular Technologies, Inc. is ... medical devices that help millions. ... cutting-edge nanotechnology that would target serious conditions such ... The platform technology was developed over a ... in funding obtained from National Institutes of Health. ...
(Date:10/16/2014)... Oct. 16, 2014 Ninety percent of children ... relapsed multiple times or failed to respond to standard ... cellular therapy, CTL019, developed at the Perelman School of ... today in The New England Journal ... builds on preliminary findings presented at the American Society ...
(Date:10/16/2014)... Oct. 16, 2014   Reliant Renal Care, Inc. ... Home Choice TM Training Center at 650 ... passing all regulatory requirements without any deficiencies, our state-of- ... admitting patients. The Center focuses on the unique needs ... in the comfort of their home. The open-access facility ...
Breaking Medicine Technology:Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases 2Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 4Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 5Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 6A New Choice For Dialysis Patients In Bessemer 2
(Date:10/18/2014)... Dwight D. Im, M.D., FACOG, Director ... The National Institute of Robotic Surgery at Mercy ... world to successfully perform a minimally-invasive hysterectomy via ... Driver, developed by Intuitive Surgical, Inc. (ISRG). , ... and Drug Administration (FDA) clearance for use in ...
(Date:10/18/2014)... Recently, BamboofloorChina.com, one of the most distinguished bamboo ... assortment of bamboo floorings to its website. For ... worldwide clients now, up to 29 percent off. , ... for sale now; most of the company’s experts have been ... than 100 different kinds of elegant bamboo products on its ...
(Date:10/18/2014)... of Neuropsychopharmacology (ECNP) is pleased to announce that the ... Swaab, for his book, We are our Brains: From ... Media Award recognises outstanding contributions to destigmatising disorders of ... € 5,000. , The ECNP Media Award was established ... better understanding of the complexity and impact of disorders ...
(Date:10/18/2014)... One major trend upcoming in this ... which are making efforts to encourage people to donate ... organ donation process more transparent and easy. , Analysts ... to grow at a CAGR of 16.85 percent over ... the major drivers in the market is an increase ...
(Date:10/18/2014)... For the second time in less than a month, ... facing US businesses. On September 23rd, the warning ... employees. And now, according to this Reuters report , ... for US businesses about possible cyber espionage attacks by a ... high-value information.” , “With the constant stream of headlines ...
Breaking Medicine News(10 mins):Health News:National Recognized Gynecologic Oncologist Dr. Dwight Im World's First to Perform Surgery Using New FDA Cleared Single Site Wristed Needle Driver Technology 2Health News:National Recognized Gynecologic Oncologist Dr. Dwight Im World's First to Perform Surgery Using New FDA Cleared Single Site Wristed Needle Driver Technology 3Health News:Brand New Bamboo Floorings Now Unveiled By BamboofloorChina.com, A Distinguished Supplier In The Market 2Health News:Dick Swaab wins the 2014 ECNP Media Award 2Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 2Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 3Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 4Health News:Another FBI Cyber Attack Warning for US Businesses 2Health News:Another FBI Cyber Attack Warning for US Businesses 3Health News:Another FBI Cyber Attack Warning for US Businesses 4
... Phase II for melanoma, to begin Phase II for breast ... cancer ... today at 9:00 a.m. EDT -, BRANFORD, Conn., April 22 CuraGen Corporation,(Nasdaq: ... the quarter ended March 31, 2008, CuraGen reported a net loss,of $6.8 million, or ...
... China, April 22 /Xinhua-PRNewswire Simcere Pharmaceutical,Group (NYSE: ... of,branded generic pharmaceuticals and manufacturer of the ... announced that it has,signed a definitive agreement ... Wuhu,Zhong Ren Pharmaceutical Co. Ltd. for a ...
... for the Service,Employees International Union claimed in an ... other acts of intimidation against,officers, directors and staff ... nothing more than "free speech.", A temporary ... Court Commission Jon Rantzman remains in effect today. ...
... treatment with drug 5-fluorouracil, study says , , MONDAY, April ... used chemotherapy drug causes memory problems and other cognitive ... brain," a new study found. , Up to 50 ... problems a year after chemotherapy treatment ended, according to ...
... DANVILLE, PA. Hearing repeated stories of suffering from ... workers, a new Geisinger-led study suggests. , In a ... Social Work Practice, Geisinger Senior Investigator Joseph Boscarino, PhD, ... and secondary trauma among 236 New York City social ...
... Appointed to Board ... of Directors, CINCINNATI, April 21, 2008 ... (Jack) F. Smith (70),will retire from the board following P&G,s April board meeting ... to:, http://www.prnewswire.com/mnr/pg/32757/ Mr. Smith has served on the board since 1995 ...
Cached Medicine News:Health News:CuraGen Reports First Quarter 2008 Financial Results 2Health News:CuraGen Reports First Quarter 2008 Financial Results 3Health News:CuraGen Reports First Quarter 2008 Financial Results 4Health News:CuraGen Reports First Quarter 2008 Financial Results 5Health News:CuraGen Reports First Quarter 2008 Financial Results 6Health News:Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd. 2Health News:SEIU Claims Right of 'Free Speech' to Stalk, Harass, and Threaten Registered Nurses According to the California Nurses Association 2Health News:Common Chemotherapy Drug Linked to Memory Problems 2Health News:Common Chemotherapy Drug Linked to Memory Problems 3Health News:Procter & Gamble Announces Board Changes 2
Button shape tip, round serrated handle, dull finish, overall length 130 mm....
... EX is a rigid gas lens with ... specific characteristics as hard contact lens, it ... excellent performance against astigmatism. The key feature ... combination of fluoromethacrylate, Siloxanylmethacrylate and methacrylic acid, ...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
Medicine Products: